Apogen targets APOBEC3B, a DNA cytosine deaminase and important source of DNA mutation in breast, head and neck, lung, bladder, cervical, ovarian, myeloma, and some blood cancers

BeneVir oncolytic viruses are based on T-StealthTM technology which helps avoid immune system detection for an effective targeting of cancer cells

Dragonfly Therapeutics develops proprietary TriNKETs (Tri-specific, NK cell Engager Therapies) which activate Natural Killer (NK) cells and turn them against  cancer cells. TriNKETs also alert other immune cells leading then to attack the cancer

Genprex developed Oncoprex™ immunogene therapy, a technology designed to administer cancer fighting genes encapsulated into nano-vesicles and taken up by tumor cells

Grid Therapeutics developed a novel antibody against a specific cell antigen in lung cancer. The antibody inhibits an essential tumor cell-protective protein, leading to tumor cell death and modulation of the adaptive immune response

Oxford Vacmedix develops therapeutics against cancer based on Recombinant Overlapping Peptides (ROP) vaccines that target cancer neoantigens

MDS Foundation

The MDS Foundation supports myelodysplastic syndromes and related neoplasms’ patients and research, with the ultimate goal of finding means to control and cure these diseases

SMEYMER

The Mexican Society of Epigenetics & Regenerative Medicine fosters epigenetics & regenerative medicine research in Mexico & Latin America, supporting scientists, students and the general public worldwide